Mission Bio

Overview

Mission Bio is a biotechnology company based in South San Francisco, California, specializing in single-cell targeted DNA sequencing technologies. The company has developed the Tapestri® platform, which utilizes droplet microfluidics and multiplex PCR-based approaches to provide high-throughput analysis of genetic variation in cancer. This platform is designed to enhance precision medicine by offering insights into tumor heterogeneity and clonal evolution, which are critical for personalized cancer therapies. Mission Bio's solutions include both off-the-shelf and customized cancer panels that can analyze thousands of DNA targets simultaneously, demonstrating high performance and sensitivity. The company’s capabilities include the design of high-plex panels with robust performance metrics, such as over 90% of reads mapped to targets, and the ability to complete workflows from cell preparation to sequence-ready libraries in as little as two days. With a focus on advancing cancer research, Mission Bio aims to improve the understanding of genetic drivers of cancer through its innovative sequencing technologies.

Industry